AstraZeneca (LSE:AZN) is navigating a period of robust growth and strategic challenges. Recent developments include an 18% ...

Two of the world’s biggest drugmakers — AstraZeneca and MSD — have hailed progress in tackling hard-to-treat cancers, ...

AstraZeneca has announced that FluMist has been approved in the US as the self-administered influenza vaccine. FluMist, a ...

FluMist approved for self-administration in the US Only influenza vaccine approved for self- or caregiver-administration at home, expanding options for influenza protection FluMist ...

AstraZeneca has completed its clinical programme supporting the transition of its respiratory medicine to a low-carbon propellant with considerably lower Global Warming Potential (GWP).

AstraZeneca's Fasenra (benralizumab) has been approved by the US FDA for the treatment of eosinophilic granulomatosis with ...

If the trial design doesn't cause regulatory issues, the results could reshape how muscle-invasive bladder tumors are treated ...

AstraZeneca Plc shares are on track for their biggest weekly decline since July 2023, after a disappointing update for the ...

Chinese police detain AstraZeneca employees over alleged data privacy breaches and unlicensed drug imports amid an ...

Prime Minister Mostafa Madbouly inspected four pharmaceutical factories on Saturday 21/9/2024 in the 6th of October City, on ...

In patients with muscle-invasive bladder cancer, Imfinzi reduced the risk of disease recurring by 32% when given alongside ...

Five AstraZeneca staff have been detained in China amid claims of potential illegal activity at the British drug giant.